Singapore – Chemoscience Pte. Ltd. (“Everlife-Chemoscience”), a leading market access and distribution company in Singapore, is pleased to announce it will provide sales, marketing and after-sales support for Corning Life Sciences’ Axygen® brand laboratory consumables in the territory of Singapore. Since 1993, Axygen products and solutions have been offered across a wide portfolio including: pipet […]

Researchers to Investigate Genetic Variants Associated with Rare Pediatric Diseases MENLO PARK, Calif. — PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its HiFi sequencing technology will be used in a pilot project for the Children’s Rare Disease Cohorts Initiative (CRDC) at Boston Children’s Hospital. Boston Children’s Hospital researchers will use HiFi whole-genome sequencing (HiFi WGS) for the purpose of investigating genetic […]

Leica Microsystems and ASI announce partnership to commercialize customizable microscope for advanced users Cell Bio, December 3-7, 2022, Booth #2025 Wetzlar, Germany –­ Leica Microsystems, a leader in microscopy and scientific instrumentation, has entered into a partnership with Applied Scientific Instrumentation (ASI) to commercialize single-objective light-sheet microscopy. The advanced system was unveiled for the first […]

New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS — Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will […]

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan’s Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. Over […]

ZURICH — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that, together with Finland’s Euformatics and Hungary’s Oncompass Medicine, the BCP-led partnership has now successfully been awarded contract for the second phase of developing standardized oncology workflows for a buyer consortium of seven leading central European hospitals*, represented by the Medical University Graz. This […]

Powerful combination of Jumpcode Single Cell RNA Boost Kit and 10x Genomics Chromium Single Cell Gene Expression platform enables scientists to boost single cell RNA sequencing. SAN DIEGO, Calif. – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced a partnership with 10x Genomics to integrate the Jumpcode Single Cell RNA […]

The collaboration pairs Eurofins Agro’s world-class analytical expertise supporting sustainable agriculture with industry-leading NeoSpectra analyzers and software services. MENLO PARK, CA –Si-Ware Systems, the creator of the NeoSpectra material analysis platform, today announced a collaboration with Eurofins Agro to investigate the application of the NeoSpectra platform to their analytical portfolio, including feed and forage applications. […]

Ball Wave Inc. (headquarters: Sendai City, Miyagi Prefecture (Japan); CEO: Shingo Akao; hereinafter “Ball Wave”) and Yanai Electric & Machinery Co.,Ltd (headquarters: Oita City, Oita Prefecture (Japan); President: Tomo Yanai; hereinafter “Yanai”) have entered into a sales representative agreement for the palm-sized gas chromatograph*1 (product name: Sylph) that was developed, manufactured, and sold by Ball […]

Disease-specific genomic information provides hope for patients and families affected by rare neurodevelopmental disorders Genomenon®, Inc., an AI-driven genomics company, announced a partnership with COMBINEDBrain, SynGAP Research Fund, and SLC-6A1 Connect. Genomenon will collaborate with the foundations and their pharma partners, delivering comprehensive genomic data on their diseases of focus with the goal of accelerating the development of precision […]